Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Vision Improvement for Patients With Age-Related Macular Degeneration
Authors not listed
VIS, Inc. · 2025
Abstract
This study is being conducted to assess the safety and efficacy of the VIS, LLC (VIS) Opti-K Low Vision Aid Device and treatment to provide vision improvement to patients with age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2025). Vision Improvement for Patients With Age-Related Macular Degeneration. <em>VIS, Inc.</em>. https://clinicaltrials.gov/study/NCT06198452
Vancouver
Anonymous. Vision Improvement for Patients With Age-Related Macular Degeneration. VIS, Inc.. 2025.
BibTeX
@misc{anon2025Vision,
title = {Vision Improvement for Patients With Age-Related Macular Degeneration},
author = {Anonymous},
journal = {VIS, Inc.},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Optimal Acuity Corporation 2020
Open access · US-GOV
Observational Study of Vision Improvement in Late Stage Dry AMD Patients by a Low Vision Aid Device
Experimental Eye Research 2015
Preprint · OA
Molecular mechanisms of subretinal fibrosis in age-related macular degeneration
Neuron 2012
Open access · OA
Mechanisms of Age-Related Macular Degeneration
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
Allergan 2015
Open access · US-GOV
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration (CEDAR Study)
Allergan 2015
Open access · US-GOV